STIM

Neuronetics, Inc. [STIM] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

STIM Stock Summary

Top 10 Correlated ETFs

STIM

Top 10 Correlated Stocks

STIM

In the News

STIM Financial details

Company Rating
-
Market Cap
128.55M
Income
-30.8M
Revenue
71.35M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
203
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
-2.41
Forward P/E
-
PEG
0.95
P/S
1.2
P/B
2.18
P/C
-
P/FCF
-2.11
Quick Ratio
3.5
Current Ratio
4.63
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.09
EPS next Y
-
EPS next Q
-
EPS this Y
-28.08%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-10.9%
Revenue last 5Y
2.63%
Revenue Q/Q
13.59%
EPS Q/Q
-42.42%
-
-
-
-
SMA20
83.26%
SMA50
284.68%
SMA100
390.8%
Inst Own
-
Inst Trans
-
ROA
-37%
ROE
-73%
ROC
-0.44%
Gross Margin
72%
Oper. Margin
-49%
Profit Margin
-50%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.03-5.07
52W High
-17.4%
52W Low
+313%
RSI
59.04
Rel Volume
9.54
Avg Volume
185.93K
Volume
1.77M
Perf Week
5.09%
Perf Month
168.18%
Perf Quarter
370.28%
Perf Half Y
316.08%
-
-
-
-
Beta
2.444
-
-
Volatility
0.38%, 0.9%
Prev Close
-13.96%
Price
4.13
Change
-15.71%

Something similar

Top by Market Cap
VOO
MSF.DE
DHR-PB
3V64.DE
LLY.SW
Top Correlated ETFs
EMQQ
FDNI
EWS
BKF
IPKW
Top Correlated Stocks
NUE
INSE
WMG
0R2L.L
DTEGY
Similar Market Cap
8123.HK
DC-A.TO
AMNA
CGO
MILN

Company Profile

Healthcare Medical - Diagnostics & Research
  • Volume Average 185.93K
  • Market Capitalization 128.55M
  • Employee 203
  • CEO Mr. Keith J. Sullivan
  • Headquarters Malvern,PA,US
  • IPO Date 2018-06-28
  • Website https://www.neurostar.com

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.